Product Images Lamotrigine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Lamotrigine NDC 42291-443 by Avkare, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

25mg - 443 30 25mg

25mg - 443 30 25mg

This appears to be a product label for Lamotr, a medication that comes in extended-release tablets. The label cautions that the product is available for prescription only and is intended to be taken once a day. Each bottle contains 30 tablets. The rest of the text is not legible due to errors.*

50mg - 444 30 50mg

50mg - 444 30 50mg

100mg - 445 30 100mg

100mg - 445 30 100mg

200mg - 446 30 200mg

200mg - 446 30 200mg

This appears to be a medication label for the drug Lamotrigine, which comes in the form of 200 mg extended-release tablets. It is intended to be taken once a day and caution is advised when dispensing the product. The label also includes a National Drug Code (NDC) and a phone number to contact the manufacturer (KARE.).*

250mg - 447 30 250mg

250mg - 447 30 250mg

This appears to be a mixture of scrambled text and relevant information. The available text describes a tablet of "Lamotr" in a "Vority Product Dispensed" format. It is proposed for "Rx Only." The tablet is an "Extended-Release" medicine and should be taken "Once A Day." The tablet is cautioned to dispense, and the packaging consists of "30 Tablets." The rest of the text is non-readable or garbled.*

300mg - 448 30 300mg

300mg - 448 30 300mg

The text appears to be a description of a medication named "Lamotrigine" which is extended-release tablets to be taken once daily, with a warning for its use. There is also a caution statement mentioned. However, there is not enough information available on its directions, usage, and side effects to provide a comprehensive description of the medication's benefits or drawbacks.*

Structural Formula - lamotrigine extended release tablets usp 1

Structural Formula - lamotrigine extended release tablets usp 1

Figure 1 - lamotrigine extended release tablets usp 2

Figure 1 - lamotrigine extended release tablets usp 2

This appears to be a chart or graph displaying the responder rates and improvement/worsening percentages for Lamotrigine Extended-Release and Placebo treatments, with numbers and percentages shown for each group. The text does not provide any further context or explanation.*

Figure 2 - lamotrigine extended release tablets usp 3

Figure 2 - lamotrigine extended release tablets usp 3

q - lamotrigine extended release tablets usp 4

q - lamotrigine extended release tablets usp 4

w - lamotrigine extended release tablets usp 5

w - lamotrigine extended release tablets usp 5

r - lamotrigine extended release tablets usp 6

r - lamotrigine extended release tablets usp 6

y - lamotrigine extended release tablets usp 7

y - lamotrigine extended release tablets usp 7

n - lamotrigine extended release tablets usp 8

n - lamotrigine extended release tablets usp 8

b - lamotrigine extended release tablets usp 9

b - lamotrigine extended release tablets usp 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.